Xencor, Inc (XNCR) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
33/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinXNCR / S&P 33.50% / 15.20% |
LoseXNCR / S&P -28.56% / 15.00% |
LoseXNCR / S&P -8.44% / 50.40% |
| 2026-Q10/3 |
LoseXNCR / S&P -21.23% / -4.33% |
LoseXNCR / S&P -23.48% / 11.30% |
LoseXNCR / S&P -24.92% / 27.70% |
| 2025-Q42/3 |
WinXNCR / S&P 30.52% / 2.65% |
WinXNCR / S&P 13.65% / 9.00% |
LoseXNCR / S&P -65.46% / 13.40% |
| 2025-Q32/3 |
WinXNCR / S&P 49.24% / 8.12% |
WinXNCR / S&P 38.16% / 4.61% |
LoseXNCR / S&P -49.71% / 13.45% |
| 2025-Q20/3 |
LoseXNCR / S&P -26.13% / 10.94% |
LoseXNCR / S&P -2.07% / 4.83% |
LoseXNCR / S&P -24.04% / 10.63% |
| 2025-Q11/3 |
LoseXNCR / S&P -53.70% / -4.27% |
LoseXNCR / S&P -25.88% / 4.98% |
WinXNCR / S&P 27.08% / 10.57% |
| 2024-Q42/3 |
WinXNCR / S&P 14.27% / 2.41% |
LoseXNCR / S&P -36.72% / 5.25% |
WinXNCR / S&P 61.71% / 6.15% |
| 2024-Q32/3 |
WinXNCR / S&P 6.23% / 5.89% |
LoseXNCR / S&P -25.19% / 5.89% |
WinXNCR / S&P 72.00% / 6.11% |
| 2024-Q22/3 |
LoseXNCR / S&P -14.46% / 4.28% |
WinXNCR / S&P 32.31% / 5.38% |
WinXNCR / S&P 45.12% / 5.12% |
| 2024-Q11/3 |
LoseXNCR / S&P 4.24% / 10.56% |
WinXNCR / S&P 75.07% / 5.71% |
LoseXNCR / S&P 2.13% / 5.59% |
| 2023-Q41/3 |
LoseXNCR / S&P 5.36% / 11.69% |
LoseXNCR / S&P 6.10% / 6.81% |
WinXNCR / S&P 136.17% / 7.78% |
| 2023-Q30/3 |
LoseXNCR / S&P -19.30% / -3.27% |
LoseXNCR / S&P -51.09% / 7.52% |
LoseXNCR / S&P -516.67% / -5.03% |
| 2023-Q20/3 |
LoseXNCR / S&P -10.47% / 8.74% |
LoseXNCR / S&P -60.81% / 9.50% |
LoseXNCR / S&P -732.35% / -8.57% |
| 2023-Q10/3 |
LoseXNCR / S&P 7.10% / 7.50% |
LoseXNCR / S&P -69.98% / 10.77% |
LoseXNCR / S&P -232.02% / -15.69% |
| 2022-Q40/3 |
LoseXNCR / S&P 0.23% / 7.56% |
LoseXNCR / S&P -40.18% / 11.88% |
LoseXNCR / S&P -169.63% / -17.99% |
| 2022-Q31/3 |
LoseXNCR / S&P -5.08% / -4.88% |
WinXNCR / S&P 82.26% / 13.47% |
LoseXNCR / S&P -580.00% / -1.41% |
| 2022-Q22/3 |
WinXNCR / S&P 2.59% / -16.10% |
WinXNCR / S&P 61.99% / 13.71% |
LoseXNCR / S&P -8.11% / 11.04% |
| 2022-Q11/3 |
LoseXNCR / S&P -33.50% / -4.60% |
WinXNCR / S&P 162.84% / 15.97% |
LoseXNCR / S&P -260.36% / 42.23% |
| 2021-Q42/3 |
WinXNCR / S&P 22.84% / 11.03% |
WinXNCR / S&P 124.22% / 15.00% |
LoseXNCR / S&P -211.57% / 96.40% |
| 2021-Q31/3 |
LoseXNCR / S&P -5.31% / 0.58% |
WinXNCR / S&P 93.17% / 10.77% |
LoseXNCR / S&P -93.01% / 69.42% |
| 2021-Q21/3 |
LoseXNCR / S&P -19.90% / 8.55% |
WinXNCR / S&P 152.48% / 6.58% |
LoseXNCR / S&P -126.62% / 51.81% |
| 2021-Q11/3 |
LoseXNCR / S&P -1.31% / 6.17% |
WinXNCR / S&P 61.09% / -1.06% |
LoseXNCR / S&P 4.72% / 7.39% |
| 2020-Q41/3 |
WinXNCR / S&P 12.48% / 12.15% |
LoseXNCR / S&P -21.70% / -3.72% |
LoseXNCR / S&P -363.04% / -33.42% |
| 2020-Q31/3 |
WinXNCR / S&P 19.76% / 8.93% |
LoseXNCR / S&P -48.80% / -2.04% |
LoseXNCR / S&P -342.37% / -27.10% |
| 2020-Q20/3 |
LoseXNCR / S&P 8.40% / 20.54% |
LoseXNCR / S&P -58.87% / -0.46% |
LoseXNCR / S&P -269.51% / -27.11% |
| 2020-Q11/3 |
WinXNCR / S&P -13.11% / -19.60% |
LoseXNCR / S&P XNCR unavailable / 3.47% |
LoseXNCR / S&P -265.63% / -14.75% |
| 2019-Q40/3 |
LoseXNCR / S&P 1.96% / 9.07% |
LoseXNCR / S&P XNCR unavailable / 5.36% |
LoseXNCR / S&P -133.82% / 2.99% |
| 2019-Q30/3 |
LoseXNCR / S&P -17.59% / 1.70% |
LoseXNCR / S&P XNCR unavailable / 5.02% |
LoseXNCR / S&P -167.82% / 0.21% |
| 2019-Q21/3 |
WinXNCR / S&P 31.78% / 4.30% |
LoseXNCR / S&P XNCR unavailable / 6.64% |
LoseXNCR / S&P -158.57% / 8.65% |
| 2019-Q10/3 |
LoseXNCR / S&P -14.10% / 13.65% |
LoseXNCR / S&P XNCR unavailable / 8.12% |
LoseXNCR / S&P -158.72% / 14.29% |
| 2018-Q41/3 |
WinXNCR / S&P -7.21% / -13.52% |
LoseXNCR / S&P XNCR unavailable / 9.05% |
LoseXNCR / S&P XNCR unavailable / 18.23% |
| 2018-Q30/3 |
LoseXNCR / S&P 5.30% / 7.71% |
LoseXNCR / S&P XNCR unavailable / 10.21% |
LoseXNCR / S&P XNCR unavailable / 19.06% |
| 2018-Q21/3 |
WinXNCR / S&P 23.45% / 3.43% |
LoseXNCR / S&P XNCR unavailable / 9.03% |
LoseXNCR / S&P XNCR unavailable / 14.46% |
| 2018-Q11/3 |
WinXNCR / S&P 36.77% / -0.76% |
LoseXNCR / S&P XNCR unavailable / 7.68% |
LoseXNCR / S&P XNCR unavailable / 12.46% |
| 2017-Q40/3 |
LoseXNCR / S&P -4.36% / 6.64% |
LoseXNCR / S&P XNCR unavailable / 7.03% |
LoseXNCR / S&P XNCR unavailable / 13.82% |
| 2017-Q31/3 |
WinXNCR / S&P 8.57% / 4.48% |
LoseXNCR / S&P XNCR unavailable / 5.68% |
LoseXNCR / S&P XNCR unavailable / 17.57% |
| 2017-Q20/3 |
LoseXNCR / S&P -11.75% / 3.09% |
LoseXNCR / S&P XNCR unavailable / 4.83% |
LoseXNCR / S&P XNCR unavailable / 17.74% |
| 2017-Q10/3 |
LoseXNCR / S&P -9.12% / 6.07% |
LoseXNCR / S&P XNCR unavailable / 3.67% |
LoseXNCR / S&P XNCR unavailable / 13.32% |
| 2016-Q41/3 |
WinXNCR / S&P 7.47% / 3.82% |
LoseXNCR / S&P XNCR unavailable / 2.09% |
LoseXNCR / S&P XNCR unavailable / 7.05% |
| 2016-Q31/3 |
WinXNCR / S&P 28.96% / 3.85% |
LoseXNCR / S&P XNCR unavailable / 0.20% |
LoseXNCR / S&P XNCR unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | XNCR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 255.23% | 20.78% |
| Annualized return | 255.23% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | XNCR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -16.96% | 83.14% |
| Annualized return | -3.65% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | XNCR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 34.76% | 319.30% |
| Annualized return | 3.03% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |